Asymptomatic sexually transmitted diseases: The case for screening

Preventive Medicine

Volumn 36, Issue 4, 2003, Pages 502-509

  Farley, Thomas A ^a,b   Cohen, Deborah A ^c,d   Elkins, Whitney ^c  

^a Louisiana Office of Public Health   (United States)

^b TULANE UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RAND CORPORATION   (United States)

Author keywords

Asymptomatic infections; Chlamydia infections; Gonorrhea; HIV; Screening; Sexually transmitted diseases

Indexed keywords

ADULT; ARTICLE; ASSAY; CHLAMYDIASIS; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GONORRHEA; HEALTH SURVEY; HUMAN; ILLNESS BEHAVIOR; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; SCREENING; SEXUALLY TRANSMITTED DISEASE; SYMPTOM; UROGENITAL TRACT INFECTION;

EID: 0037376873     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-7435(02)00058-0     Document Type: Article

References (33)

1. Eng T.R., Butler W.T. The neglected health and economic impact of STDs. Eng T.R., Butler W.T. The hidden epidemic confronting sexually transmitted diseases . 1997;28-68 National Academy Press, Washington, DC.
2. Fleming D.T., Wasserheit J.N. From epidemiological synergy to public health policy and practice the contribution of other sexually transmitted diseases to sexual transmission of HIV infection . Sex Transm Infect. 75:1999;3-17.
3. HIV prevention through early detection and treatment of other sexually transmitted diseases - United States recommendations of the Advisory Committee for HIV and STD Prevention . MMWR. 47:1998;1-24.
4. Chernesky M.A., Jang D., Lee H., et al. Diagnosis of Chlamydia trachomatis infection in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol. 32:1994;2682-2685.
5. Lee H., Chernesky M., Schachter J., et al. Diagnosis of chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet. 345:1995;213-216.
6. Smith K., Ching S., Lee H., et al. Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic. J Clin Microbiol. 33:1995;455-457.
7. 1998 guidelines for treatment of sexually transmitted diseases. MMWR. 47:(No. RR-1):1998;49-69.
8. Johnson R.E., Green T.A., Schachter J., Jones R.B., Hook E.W. 3rd, Black C.M., Martin D.H., St Louis M.E., Stamm W.E. Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol. 38:2000;4382-4386.
9. Berrios D.C., Avins A.L., Haynes-Sanstad K., Eversley R., Woods W.J. Screening for human immunodeficiency virus antibody in urine. Arch Pathol Lab Med. 119:1995;139-141.
10. Moran J.S., Handsfield H.H. Neisseria gonorrhoeae. Yu V.L., Merigan T.C., Barriere S.L. Antimicrobial therapy and vaccines. 1999;295-303 Williams and Wilkins, Baltimore, MD.
11. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR 1998:47(RR-1).
12. Moran J.S., Levine W.C. Drugs of choice for treatment of uncomplicated gonococcal infections. Clin Infect Dis. 20:(Suppl 1):1995;S47-65.
13. Sexually transmitted diseases surveillance 1999 supplement gonococcal isolate surveillance project (GISP) annual report - 1999 . October 2000;U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA.
14. Brown S.T., Thompson S.E., Biddle J.W., et al. Treatment of uncomplicated gonococcal infection with trimethoprim-sulfamethoxazole. Sex Transm Dis. 9:1982;9-14.
15. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR. 42:(RR-12):1993;27-30.
16. Stamm W.E., Koutsky L.A., Benedetti K., Jourden J.L., Brunham R.C., Holmes K.K. Chlamydia trachomatis urethral infections in men prevalence, risk factors, and clinical manifestations . Ann Intern Med. 100:1984;47-51.
17. Gaydos C.A., Howell M.R., Pare B., et al. Chlamydia trachomatis infections in female military recruits. New Engl J Med. 339:1998;739-744.
18. Marrazzo J.M., White C.L., Krekeler B., et al. Community-based screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med. 127:1997;796-803.
19. Marrazzo J.M., Whittington W.L., Celum C.L., et al. Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics. Sex Transm Dis. 28:2001;219-225.
20. Handsfield H.H., Lipman T.O., Harnisch J.P., Tronca E., Holmes K.K. Asymptomatic gonorrhea in men diagnosis, natural course, prevalence, and significance . New Engl J Med. 290:1974;117-123.
21. Pack R.P., Diclemente R.J., Hook E.W. 3rd, Oh M.K. High prevalence of asymptomatic STDs in incarcerated minority male youth a case for screening . Sex Transm Dis. 27:2000;175-177.
22. Todd C.S., Haase C., Stoner B. Emergency department screening for asymptomatic sexually transmitted infections. Am J Public Health. 91:2001;461-464.
23. Hook E.W. 3rd, Handsfield H.H. Gonococcal infections in the adult. Holmes K.K., et al. Sexually transmitted diseases. 3rd ed: 1999;451-466 McGraw-Hill, New York.
24. Cates W. Jr, Wasserheit J.N. Genital chlamydial infections epidemiology and reproductive sequelae . Am J Obstet Gynecol. 164:1991;1771-1781.
25. Garnett G.P., Bowden J.F. Epidemiology and control of curable sexually transmitted diseases: opportunities and problems. Sex Transm Dis. 27:2000;588-599.
26. Ellerbeck E.F., Vlahov E., Libonati J.P., Salive M.E., Brewer T.F. Gonorrhea prevalence in Maryland state prisons. Sex Transm Dis. 16:1989;165-167.
27. Embling M.L., Monroe K.W., Oh M.K., Hook E.W. 3rd. Opportunistic urine ligase chain reaction screening for sexually transmitted diseases in adolescents seeking care in an urban emergency department. Ann Emerg Med. 36:2000;28-32.
28. Cohen D.A., Nsuami M., Etame R.B., Tropez-Sims S., Abdalian S., Farley T.A., Martin D.H. A school-based chlamydia control program using DNA amplification technology. Pediatrics. 101:1998;E1.
29. Beltrami J.F., Cohen D.A., Hamrick J.T., Farley T.A. Rapid screening and treatment for sexually transmitted diseases in arrestees a feasible control measure . Am J Public Health. 87:1997;1423-1426.
30. Welte R., Kretzschmar M., Leidl R., Van den Hoek A., Jager J.C., Postma M.J. Cost-effectiveness of screening programs for Chlamydia trachomatis. Sex Transm Dis. 27:2000;518-529.
31. Goddeeris J.H., Bronken T.P. Benefit-cost analysis of screening a comparison of tests for gonorrhea . Med Care. 23:1985;1242-1255.
32. U.S. Department of Health and Human Services, Public Health Service. Clinician's handbook of preventive services, 2nd ed. Washington, DC; 1998.
33. Hillis S.D., Nakashima A., Amsterdam L., et al. The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plan Persp. 27:1995;108-111.